Isoproterenol: Difference between revisions

(Created page with "== Adult Dosing == 2-10mcg/min IV by continuous infusion == Indications == *Refractory torsades *Refractory symptomatic bradycardia == Mechanism of Action == *Beta agonist == ...")
 
No edit summary
Line 1: Line 1:
== Adult Dosing ==
==General==
2-10mcg/min IV by continuous infusion
*Type: Beta agonist
*Dosage Forms:
*Common Trade Names:
 
==Adult Dosing==
*2-10mcg/min IV by continuous infusion
 
==Pediatric Dosing==
 
==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]:
*[[Lactation risk categories|Lactation risk]]:
*Renal Dosing
**Adult
**Pediatric
*Hepatic Dosing
**Adult
**Pediatric


== Indications ==
== Indications ==
Line 6: Line 23:
*Refractory symptomatic bradycardia
*Refractory symptomatic bradycardia


== Mechanism of Action ==
==Contraindications==
*Beta agonist
*Allergy to class/drug


== Adverse Drug Rxns ==
==Adverse Reactions==
*Dramatic increase in O2 demand
*Dramatic increase in O2 demand
*V-tach (use lowest dose possible)
*V-tach (use lowest dose possible)
==Pharmacology==
*Half-life:
*Metabolism:
*Excretion:
*Mechanism of Action:


== Kinetics ==
== Kinetics ==
*Onset of action = 1-5min
*Onset of action = 1-5min
*Duration of action = 1-2hr
*Duration of action = 1-2hr
==Comments==


==See Also==
==See Also==
[[Antiarrhythmics]]
*[[Antiarrhythmics]]


==References==
<references/>
[[Category:Drugs]]
[[Category:Drugs]]

Revision as of 13:06, 1 June 2015

General

  • Type: Beta agonist
  • Dosage Forms:
  • Common Trade Names:

Adult Dosing

  • 2-10mcg/min IV by continuous infusion

Pediatric Dosing

Special Populations

Indications

  • Refractory torsades
  • Refractory symptomatic bradycardia

Contraindications

  • Allergy to class/drug

Adverse Reactions

  • Dramatic increase in O2 demand
  • V-tach (use lowest dose possible)

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:
  • Mechanism of Action:

Kinetics

  • Onset of action = 1-5min
  • Duration of action = 1-2hr

Comments

See Also

References